Sue-Anne McLachlan

Uncertainty and novel clinical trial designs in oncology – when should equipoise matter?

Equipoise is usually considered a requirement for the ethical conduct of phase III randomised controlled trials. Notwithstanding theoretical critiques since the concept’s initial proposal, equipoise has remained an important moral consideration. In oncology, many research questions are now pursued via clinical trial de...